| 09:00–09:30 | Welcoming Remarks and Overview of Conference Objectives Dmitry Orlov, Russian Academy of Medical Sciences Mikhail Perelman, Moscow Medical Academy Gail Cassell, Eli Lilly and Company | |
| 09:30–12:30 | Roundtable #1: Magnitude of the Burden of Drug Resistant Tuberculosis—Local and Global Perspectives | |
| Co-Chairs: | Marina Yakimova, Central TB Research Institute Jeffrey Drazen, New England Journal of Medicine | |
| Global Status of MDR/XTR Tuberculosis, 30 min Salmaan Keshavjee, Chair, Green Light Committee (GLC) Harvard Medical School Epidemiology of TB in the Russian Federation, 30 min Marina Yakimova, Central TB Research Institute | ||
| Prevalence of Drug Resistance at the Initiation of Second-Line Drugs in Eight Countries, 30 min Peter Cegielski, U.S. Centers for Disease Control and Prevention | ||
| Profile of MDR/XDR in South Africa Based Upon Laboratory Data, 30 min Gerrit Coetzee, National Health Laboratory Service, South Africa | ||
| Current Status of Disease Burden and Programmatic Management of MDR/XDR TB in China, 30 min Mingting Chen, Center for Disease Control and Prevention, China | ||
| Roundtable Discussion, 30 min | ||
| 12:30–13:30 | Lunch | |
| 13:30–15:30 | Roundtable #2: The Capability of Health Care Systems to Keep Up with the Spread of MDR TB | |
| Co-Chairs: | Elena Skachkova, Central Research Institute for the Organization and Informatization of Health Care, Moscow Dale Nordenberg, Novasano Health and Science | |
| Monitoring System of MDR TB, 30 min Elena Skachkova, Central Research Institute for the Organization and Informatization of Health Care, Moscow | ||
| Surveillance Systems for TB Drug Resistance in China, 30 min Renzhong Li, Center for Disease Control and Prevention, China | ||
| Laboratory lnformation Barriers to MDR TB Control, 30 min Dale Nordenberg, Novasano Health and Science | ||
| Roundtable Discussion, 30 min | ||
| 15:30 – 15:45 | Break | |
| 15:45 – 17:45 | Roundtable #3: Treatment of Drug-Resistant TB in Vulnerable Patient Populations | |
| Co-Chairs: | Irina Vasilyeva, Central TB Research Institute Janet Tobias, Ikana Media | |
| Treatment of MDR TB, the CTRI Experience, 15 min Irina Vasilyeva, Central TB Research Institute | ||
| Approach to the Treatment of Children Infected with Multidrug-Resistant TB, 15 min Elena Ovsiankina,1 Central TB Research Institute | ||
| HIV and MDR TB Co-Infection, 15 min Olga Frolova, Federal Center of TB/AIDS Treatment | ||
| MDR TB in Cases of Substance Abuse, 15 min Piotr Golubchikov, Regional Anti-Tuberculosis Dispensary, Tomsk | ||
| Epidemiology of TB in the Prison System of the Russian Federation, 15 min Svetlana Safonova, Federal Correction System, Russian Federation | ||
| Response Panel and Roundtable Discussion, 45 min Sonya Shin, Harvard Medical School Carlos Pérez-Vélez, National Jewish Hospital, Denver Gary Reubenson, Rahima Moosa Mother & Child Hospital, South Africa | ||
| 17:45–18:30 | Gaps in TB Research: Meeting Report from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) Barbara Laughon, NIAID/NIH Alexandr Apt, Central Institute for Tuberculosis, Moscow | |
| Opportunities for International Cooperation Stuart Politi, Civilian Research and Development Foundation | ||
From: Appendix A, Agenda
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.